Visionary Holdings announces agreement on proposed $20M strategic investment

Visionary Holdings (GV) announced that it has entered into an investment cooperation agreement with Qingdao Xihai Rongke Enterprise Operation Management Co., Ltd. in connection with a proposed $20M strategic investment for the company’s Qingdao anti-aging project in Qingdao West Coast New Area, China. “Under the agreement, the parties plan to establish a project company to serve as the operating entity for the collaboration. The project company is expected to establish the ‘GV China Anti-Aging Research Center’ in Qingdao West Coast New Area, with an initial focus on research and translational development in areas including cell therapy and biologics. In parallel, the project company is also expected to begin building out a ‘GV Anti-Aging Health Management Center’ chain model in China, initially with a focus on the Shandong market and with the goal of introducing internationally aligned products and service standards. According to the cooperation framework, the investor intends to make a total investment of no less than $20M into the project company in two phases. The initial phase is structured around three milestone-based payments: 30% upon establishment of the project company and opening of its capital account, 40% upon completion of renovation of the research center and installation of equipment, and the final 30% after the first flagship center opens and generates its first month of operating data. A second-phase investment of $10M is contemplated subject to the Company’s subsequent development progress,” the company stated.